Fri, July 10, 2020

Larry Biegelsen Maintained (ABT) at Buy with Increased Target to $122 on, Jul 10th, 2020

Larry Biegelsen of Wells Fargo, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $120 to $122 on, Jul 10th, 2020.

Larry has made no other calls on ABT in the last 4 months.



There are 9 other peers that have a rating on ABT. Out of the 9 peers that are also analyzing ABT, 1 agrees with Larry's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $93 on, Wednesday, April 8th, 2020


These are the ratings of the 8 analyists that currently disagree with Larry


  • David Lewis of "Morgan Stanley" Maintained at Buy with Decreased Target to $100 on, Thursday, June 25th, 2020
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $102 on, Friday, April 17th, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $109 on, Friday, April 17th, 2020
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $106 on, Friday, April 17th, 2020
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $109 on, Friday, April 17th, 2020
  • Raj Denhoy of "Jefferies" Maintained at Strong Buy with Increased Target to $113 on, Friday, April 17th, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $108 on, Friday, April 17th, 2020
  • Kevin Huang of "CFRA" Maintained at Strong Buy with Increased Target to $101 on, Thursday, April 16th, 2020